Safeguarding
Sight

Myopia is more than an epidemic. It’s a global crisis that many parents are not even aware of. Enter the Global Myopia Awareness Coalition—a diverse group of eye care companies, eye health associations, and providers locking arms to protect today’s youth from the short-term challenges and long-term effects of myopia.

“I’m proud to serve as GMAC Board Chair on behalf of EssilorLuxottica, and I’m excited to build on our successful programs in 2022 to further enhance our leadership role in driving public awareness of the childhood myopia epidemic,” said Dr. Knight. “This unique coalition of influential companies has been a key driver of getting industry focused on pediatric myopia treatment, and it is so gratifying to be part of this effort.”

Millicent Knight

OD, FAAO, FAARM, FNAP
SVP, EssilorLuxottica, Customer Development Group

The GMAC Story

In late 2018, a number of companies and associations came together to partner globally to increase public awareness of childhood myopia, the risk of eye disease associated with myopia, and encourage consumers to ask their eye care professionals about treatment options for childhood myopia.

Happy children
Happy Girl

GMAC stands shoulder to shoulder with industry leaders and eye doctors to stop the myopia epidemic.

The GMAC Mission

The Global Myopia Awareness Coalition (GMAC) is a coalition of leading ophthalmic companies and eye health associations with a mission to increase public awareness about the growing prevalence and consequences of myopia, especially in children.

GMAC develops messaging campaigns for the public and works with health care professionals and allied organizations to educate both parents and children to access early and regular eye exams and be more receptive to treatment recommendations from their eye care professionals.

Who Is GMAC?

Never before have so many leading eyecare organizations joined forces against the devastating consequences of myopia.

CooperVisionjohnson & johnsonAlconBausch + LombBHVIeyes onEuclidIAPBMeniconPentaVisionSinergEyesSydnexisTreehouse EyesVTI redefining visionvylumaWorld Council of Optometry

Meet the Individuals Committed to Myopia Awareness

The Global Myopia Awareness Coalition is led by a Board of Directors that guides our strategic direction and by member companies that help accomplish our shared mission.

Millicent Knight
Millicent Knight

Essilor USA

Juan Carlos Aragon
Juan Carlos Aragon

CooperVision

Matt Oerding
Matt Oerding

Treehouse Eyes

Kovin Naidoo
Kovin Naidoo

Essilor

Bill Scott
Bill Scott

Jobson

Marc Ferrara
Marc Ferrara

Jobson

Lisa McAlister
Lisa McAlister

Johnson & Johnson

Raul Trillo
Raul Trillo

Vyluma

Layna Mendlinger
Layna Mendlinger

VTI

Sandra Block
Sandra Block

World Council Of Optometry

Nick Parker
Nick Parker

The International Agency for the Prevention of Blindness

Matt Geller
Matt Geller

Eyes On Eyecare

Significant Milestones

Since GMAC was formed in 2019, it has launched five successful consumer campaigns in the U.S. dedicated to raising awareness of myopia in children and motivating parents to ask about new treatment options.

January 2019
Forming Partnerships

We formed partnerships with allied health care professionals and other stakeholders in children’s eye health and vision—including pediatricians,
ophthalmologists, optometrists, and school nurses.

Forming Partnerships
September 2021
Observing Trends

Two years later, we set out to assess the changes in awareness and existing perceptions around myopia and comprehensive eye exams since GMAC was formed. We conducted a survey of social listening and analysis of Google trends among 1.5K parents and found an increased awareness of myopia.

Observing Trends
Testing Messaging
September 2019
Testing Messaging

We tested potential messaging with over 4K parents in the U.S. through a rigorous qualitative and quantitative research approach.

Going Global
October 2021
Going Global

We put the “global” into our acronym and extended our reach across the pond in the UK in 2022 to understand baseline awareness of myopia, short-sightedness, and new treatment options. We leveraged those findings to inform the UK consumer campaign. We will continue to explore additional markets in 2022 and beyond.